ReviewNeuromolecular medicine2026

Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) as a Biomarker of Neurodysfunction.

Victoria Linden de Rezende et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.